PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES
May 1, 2011, 00:00
10.1016/j.jval.2011.02.209
https://www.valueinhealthjournal.com/article/S1098-3015(11)00348-2/fulltext
Title :
PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00348-2&doi=10.1016/j.jval.2011.02.209
First page :
A36
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
756